The Biopreservation Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 16.2 billion by 2030 at a CAGR of 28.4% during the forecast period of 2023-2030.
Biopreservation enhances the shelf life of food by introducing natural or controlled antimicrobials or microorganisms. The rising need for biopreservatives in the pharmaceutical industry will boost market prospects. The increased number of people diagnosed with chronic diseases such as diabetes, heart disease, and maladies affecting the joints, nerves, bones, and other organs may accelerate the acceptance of regenerative therapies. Biopreservation strategies are critical for regenerative medicines to maintain their integrity and effectiveness.
.png)
DRIVERS
Increasing prevalence of chronic diseases, development of regenerative medicine
Rising biospecimen testing drives the market growth
Patients with chronic diseases such as diabetes, heart disease, and degenerative ailments affecting joints, nerves, bones, among others, are increasing the demand for biopreservation. Furthermore, regenerative therapies necessitate substantial biopreservation techniques to maintain their integrity and effectiveness. The increasing use of regenerative treatments has directly contributed to the exponential growth in demand for biopreservation. Furthermore, increased testing by the general population as a result of various health issues has raised the demand on the healthcare industry to retain biospecimens. The increasing preservation workload has directly raised the demand for biopreservation approaches.
RESTRAIN
High cost of biobanking in biopreservation
R&D in media solutions that allow for room temperature storage of biospecimens is projected to restraints the global bio preservation market's expansion. Biomatrica, Inc., for example, provides room temperature sample stabilization medium solutions such as DNA stable and RNA stable. Such alternatives jeopardize demand for freezers and refrigerators, limiting market growth. Furthermore, the high cost recovery model of biobanking is projected to hinder biopreservation adoption.
OPPORTUNITY
The favourable government funding initiatives
The availability of enough funding from venture capitalists, governments, or parent organizations, together with patient education, is projected to provide profitable growth possibilities for companies in the global biopreservation market. Furthermore, growing and high-growth regions like as China, Brazil, India, Eastern Europe, the Middle East, and Latin America present several potential for participants in the global biopreservation market. This is because economic progress in these places has provided the population with greater spending power as disposable income has increased.
CHALLENGES
Unavailability of skilled professionals
Inadequate cybersecurity measures
Some of the contributing variables include the high cost of labor training and software uniformity.
By Product
Equipment
Freezers
Refrigerators
Consumables
Vials
Straws
Microtiter Plates
Bags
Liquid Nitrogen
Media
Pre-formulated
Home-brew
Laboratory Information Management System
In 2022, Equipment segment is expected to held the highest market share of 78.8% during the forecast period due to rising need for bio-banking to store stem cells, DNA, plasma and tissue culture. The broad adoption and use of preservation has benefited adequate storage capacity and low maintenance, which is projected to drive the market.
By Application
Regenerative Medicine
Cell Therapy
Gene Therapy
Others
Bio-banking
Human Eggs
Human Sperms
Veterinary IVF
Drug Discovery
.png)
In 2022, Bio-banking segment is expected to dominate the market growth of 70.7% during the forecast period due to rising awareness for Stem cell preservation, Similarly, sperm and egg banking, as well as the use of animal assisted reproduction technology, are prohibited. Pharmaceutical companies work with reserve biobanks and hospitals on tissue preservation.
North America held a significant market share of around 38.2% in 2022 due to the government organizations and different bio-banking institutes that contribute to the penetration of biopreservation techniques, the United States is expected to have considerable growth in the biopreservation market. For example, the National Institutes of Health (NIH) funds biospecimen collection in biorepositories and biobanks, while the National Cancer Institute (NCI) contributes to the management of such bio-banking initiatives. These biobanks assist the country's research and clinical trial programs, boosting the demand for biopreservation technology.
Asia-Pacific is witness to expand fastest CAGR rate of 16.8% during the forecast period due to the expanding financing support for techniques and services in bio-banking, and increasing partnerships and collaborations following biopreservation approaches.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Azenta US, Inc., Biomatrica, Inc., BioLife Solutions, MVE Biological Solutions, LabVantage Solutions, Inc., Taylor-Wharton., Thermo Fisher Scientific, Inc., Panasonic Corporation, X-Therma Inc., PrincetonCryo., Hamad Medical Corporation, Qatar BioBank, and Others.
BioLife Solutions, Inc., in June 2023, BioLife Solutions, Inc. expanded its CRF product line by introducing a new large-capacity controlled-rate freezer (CRF). This new product will enable the business to support autologous and allogeneic CGT customers, as well as its commercial-scale manufacturing, while also meeting critical customer requirements for high-volume cell therapies.
Hamad Medical Corporation and Qatar BioBank, in January 2023, Hamad Medical Corporation and Qatar BioBank have established a new tissue biobank service in Qatar to enable researchers with access to high-quality tissue samples.
Thermo Fisher Scientific Inc., in Jan 2023, Thermo Fisher Scientific Inc. has completed a mergers and acquisitions (M&A) agreement with The Binding Site Group ("The Binding Site"), a global leader in specialty diagnostics, to expand its existing specialty diagnostics portfolio and include pioneering breakthrough in multiple myeloma diagnoses and monitoring.
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.2 Billion |
| Market Size by 2030 | US$ 16.2 Billion |
| CAGR | CAGR of 28.4 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Equipment, Media, Laboratory Information Management System) • By Application (Regenerative Medicine, Bio-banking, Drug Discovery) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Azenta US, Inc., Biomatrica, Inc., BioLife Solutions, MVE Biological Solutions, LabVantage Solutions, Inc., Taylor-Wharton., Thermo Fisher Scientific, Inc., Panasonic Corporation, X-Therma Inc., PrincetonCryo., Hamad Medical Corporation, Qatar BioBank |
| Key Drivers | • Increasing prevalence of chronic diseases, development of regenerative medicine • Rising biospecimen testing drives the market growth |
| Market Opportunity | • The favourable government funding initiatives |
Ans: USD 16.2 billion is expected to grow by 2030.
Ans: Biopreservation Market is anticipated to expand by 28.4% from 2023 to 2030.
Ans: Biopreservation Market size was valued at USD 2.2 billion in 2022.
Ans: North America is dominating the market.
Ans: Increasing prevalence of chronic diseases, development of regenerative medicine.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Biopreservation Market Segmentation, By Product
8.1 Equipment
8.1.1 Freezers
8.1.2 Refrigerators
8.1.3 Consumables
8.1.3.1 Vials
8.1.3.2 Straws
8.1.3.3 Microtiter Plates
8.1.3.4 Bags
8.1.4 Liquid Nitrogen
8.2 Media
8.3 Laboratory Information Management System
9. Biopreservation Market Segmentation, By Application
9.1 Regenerative Medicine
9.1.1 Cell Therapy
9.1.2 Gene Therapy
9.1.3 Others
9.2 Bio-banking
9.2.1 Human Eggs
9.2.2 Human Sperms
9.2.3 Veterinary IVF
9.3 Drug Discovery
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Biopreservation Market by Country
10.2.2 North America Biopreservation Market by Product
10.2.3 North America Biopreservation Market by Application
10.2.4 USA
10.2.4.1 USA Biopreservation Market by Product
10.2.4.2 USA Biopreservation Market by Application
10.2.5 Canada
10.2.5.1 Canada Biopreservation Market by Product
10.2.5.2 Canada Biopreservation Market by Application
10.2.6 Mexico
10.2.6.1 Mexico Biopreservation Market by Product
10.2.6.2 Mexico Biopreservation Market by Application
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Biopreservation Market by Country
10.3.1.2 Eastern Europe Biopreservation Market by Product
10.3.1.3 Eastern Europe Biopreservation Market by Application
10.3.1.4 Poland
10.3.1.4.1 Poland Biopreservation Market by Product
10.3.1.4.2 Poland Biopreservation Market by Application
10.3.1.5 Romania
10.3.1.5.1 Romania Biopreservation Market by Product
10.3.1.5.2 Romania Biopreservation Market by Application
10.3.1.6 Hungary
10.3.1.6.1 Hungary Biopreservation Market by Product
10.3.1.6.2 Hungary Biopreservation Market by Application
10.3.1.7 Turkey
10.3.1.7.1 Turkey Biopreservation Market by Product
10.3.1.7.2 Turkey Biopreservation Market by Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Biopreservation Market by Product
10.3.1.8.2 Rest of Eastern Europe Biopreservation Market by Application
10.3.2 Western Europe
10.3.2.1 Western Europe Biopreservation Market by Country
10.3.2.2 Western Europe Biopreservation Market by Product
10.3.2.3 Western Europe Biopreservation Market by Application
10.3.2.4 Germany
10.3.2.4.1 Germany Biopreservation Market by Product
10.3.2.4.2 Germany Biopreservation Market by Application
10.3.2.5 France
10.3.2.5.1 France Biopreservation Market by Product
10.3.2.5.2 France Biopreservation Market by Application
10.3.2.6 UK
10.3.2.6.1 UK Biopreservation Market by Product
10.3.2.6.2 UK Biopreservation Market by Application
10.3.2.7 Italy
10.3.2.7.1 Italy Biopreservation Market by Product
10.3.2.7.2 Italy Biopreservation Market by Application
10.3.2.8 Spain
10.3.2.8.1 Spain Biopreservation Market by Product
10.3.2.8.2 Spain Biopreservation Market by Application
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Biopreservation Market by Product
10.3.2.9.2 Netherlands Biopreservation Market by Application
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Biopreservation Market by Product
10.3.2.10.2 Switzerland Biopreservation Market by Application
10.3.2.11 Austria
10.3.2.11.1 Austria Biopreservation Market by Product
10.3.2.11.2 Austria Biopreservation Market by Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Biopreservation Market by Product
10.3.2.12.2 Rest of Western Europe Biopreservation Market by Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Biopreservation Market by Country
10.4.2 Asia Pacific Biopreservation Market by Product
10.4.3 Asia Pacific Biopreservation Market by Application
10.4.4 China
10.4.4.1 China Biopreservation Market by Product
10.4.4.2 China Biopreservation Market by Application
10.4.5 India
10.4.5.1 India Biopreservation Market by Product
10.4.5.2 India Biopreservation Market by Application
10.4.6 Japan
10.4.6.1 Japan Biopreservation Market by Product
10.4.6.2 Japan Biopreservation Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Biopreservation Market by Product
10.4.7.2 South Korea Biopreservation Market by Application
10.4.8 Vietnam
10.4.8.1 Vietnam Biopreservation Market by Product
10.4.8.2 Vietnam Biopreservation Market by Application
10.4.9 Singapore
10.4.9.1 Singapore Biopreservation Market by Product
10.4.9.2 Singapore Biopreservation Market by Application
10.4.10 Australia
10.4.10.1 Australia Biopreservation Market by Product
10.4.10.2 Australia Biopreservation Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Biopreservation Market by Product
10.4.11.2 Rest of Asia-Pacific Biopreservation Market by Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Biopreservation Market by Country
10.5.1.2 Middle East Biopreservation Market by Product
10.5.1.3 Middle East Biopreservation Market by Application
10.5.1.4 UAE
10.5.1.4.1 UAE Biopreservation Market by Product
10.5.1.4.2 UAE Biopreservation Market by Application
10.5.1.5 Egypt
10.5.1.5.1 Egypt Biopreservation Market by Product
10.5.1.5.2 Egypt Biopreservation Market by Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Biopreservation Market by Product
10.5.1.6.2 Saudi Arabia Biopreservation Market by Application
10.5.1.7 Qatar
10.5.1.7.1 Qatar Biopreservation Market by Product
10.5.1.7.2 Qatar Biopreservation Market by Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Biopreservation Market by Product
10.5.1.8.2 Rest of Middle East Biopreservation Market by Application
10.5.2 Africa
10.5.2.1 Africa Biopreservation Market by Country
10.5.2.2 Africa Biopreservation Market by Product
10.5.2.3 Africa Biopreservation Market by Application
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Biopreservation Market by Product
10.5.2.4.2 Nigeria Biopreservation Market by Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Biopreservation Market by Product
10.5.2.5.2 South Africa Biopreservation Market by Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Biopreservation Market by Product
10.5.2.6.2 Rest of Africa Biopreservation Market by Application
10.6 Latin America
10.6.1 Latin America Biopreservation Market by Country
10.6.2 Latin America Biopreservation Market by Product
10.6.3 Latin America Biopreservation Market by Application
10.6.4 Brazil
10.6.4.1 Brazil Biopreservation Market by Product
10.6.4.2 Brazil Biopreservation Market by Application
10.6.5 Argentina
10.6.5.1 Argentina Biopreservation Market by Product
10.6.5.2 Argentina Biopreservation Market by Application
10.6.6 Colombia
10.6.6.1 Colombia Biopreservation Market by Product
10.6.6.2 Colombia Biopreservation Market by Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Biopreservation Market by Product
10.6.7.2 Rest of Latin America Biopreservation Market by Application
11. Company Profile
11.1 Azenta US, Inc.
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Products Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Biomatrica, Inc.
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Products Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 BioLife Solutions
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Products Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 MVE Biological Solutions
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Product/Products Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 LabVantage Solutions, Inc.
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Products Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Taylor-Wharton.
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Products Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Products Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Panasonic Corporation
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Products Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 X-Therma Inc.
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Products Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 PrincetonCryo.
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Products Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 Hamad Medical Corporation
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Product/Products Offered
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 Qatar BioBank
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Product/Products Offered
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 Others
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Prostate Health Market Size was valued at USD 34.05 billion in 2022, and is expected to reach USD 66.86 billion by 2030 and grow at a CAGR of 8.8% over the forecast period 2023-2030.
Point-of-care Ultrasound Market size was USD 1.17 billion in 2023 and is expected to Reach USD 3.43 Billion by 2031 and grow at a CAGR of 14.4% over the forecast period of 2024-2031.
In 2022, The Alopecia Treatment Market size amounted to USD 8.0 Billion & is estimated to reach USD 16.12 Billion by 2030 and increase at a compound annual growth rate of 9.2% between 2023 and 2030.
The In Vitro Fertilization (IVF) market is projected to hit USD 38.96 billion by 2031 from USD 25.2 Billion in 2023, at a CAGR of 5.6% from 2024 to 2031.
The Toxoid Vaccine market size was worth US$ 5.61 billion in 2022 and is estimated to reach US$ 8.22 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2023-2030.
The Military Wearable Medical Device Market Size was valued at USD 25.22 billion in 2022 and is expected to reach USD 207.04 billion by 2030, and grow at a CAGR of 30.1% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
